Abstract Oxysterol binding protein-related protein 2 (ORP2) is a member of the oxysterol binding protein family, previously shown to bind 25-hydroxycholesterol and implicated in cellular cholesterol metabolism. We show here that ORP2 also binds 22(R)-hydroxycholesterol [22(R)OHC], 7-ketocholesterol, and cholesterol, with 22(R)OHC being the highest affinity ligand of ORP2 (K d 1.4 3 10 28 M). We report the localization of ORP2 on cytoplasmic lipid droplets (LDs) and its function in neutral lipid metabolism using the human A431 cell line as a model. The ORP2 LD association depends on sterol binding: Treatment with 5 mM 22(R)OHC inhibits the LD association, while a mutant defective in sterol binding is constitutively LD bound. Silencing of ORP2 using RNA interference slows down cellular triglyceride hydrolysis. Furthermore, ORP2 silencing increases the amount of (5), and inhibit the processing of sterol regulatory element binding proteins (SREBPs) via binding to the Insig proteins, which retain SREBP/SCAP complexes in the endoplasmic reticulum (ER) (6). The cytosolic oxysterol receptor, oxysterol binding protein (OSBP), was identified in the 1980s (7). Families of OSBP-related proteins (ORPs) have recently been identified in practically all eukaryotic organisms studied (8). Most of the information on the ORP proteins has been obtained using yeast (Saccharomyces cerevisiae) or mammalian cells. The yeast ORPs (Osh proteins) are suggested to play major roles in the intracellular transport of sterols (9), in vesicle budding from the Golgi apparatus (10, 11), and in the establishment of cell polarity (12, 13), while mammalian ORPs have been suggested to participate in the regulation of lipid metabolism, vesicle transport, and cellular signaling (8).
to late endosomes (14) , ORP3, -6, and -7 to the plasma membrane (15) , and OSBP (16, 17) and ORP9 (18) to the Golgi complex. OSBP is targeted to Golgi complex in response to treatment of cells with its high-affinity ligand 25-hydroxycholesterol (25OHC). In several cases, the ORP pleckstrin homology domains are known to mediate the binding of phosphoinositides, but also the ORDs of ORP1, -2, -9, and -10 seem to be capable of binding these negatively charged phospholipids (19) (20) (21) . A motif called FFAT (two phenylalanines in an acidic track), which mediates the binding to the ER resident protein VAP-A (for vesicle-associated membrane protein-associated protein), specifies association of several ORPs with the ER membranes (22) .
Lipid droplets (LDs) are intracellular organelles composed of a neutral lipid core surrounded by a monolayer of phospholipids and cholesterol (23) (24) (25) . In adipocytes, their main function is to store energy in the form of triglycerides (TGs), while in steroidogenic cells, LDs store cholesteryl esters (CEs) to be used as precursors for steroid hormone biosynthesis. In other cell types, LDs serve as storage organelles for fatty acids and cholesterol needed for cell membrane renewal and signaling purposes.
Whereas the role of ORPs in cholesterol metabolism has been addressed in a number of studies, their possible roles in TG metabolism have gained less interest. In the study of Yan and Olkkonen (8) , overexpression of OSBP in mouse liver resulted in an increased amount of TG in liver tissue as well as enhanced secretion of TG into the circulation, apparently due to elevated activity of the lipogenic transcription factor SREBP-1c. On the other hand, overexpression of ORP2, a ubiquitously expressed ORP family member (26) , was shown to decrease the amount of both TG and CE in Chinese hamster ovary (CHO) cells (27) . In this study, we examine further the role of ORP2 in neutral lipid metabolism in the human A431 cell system. We show that ORP2 binds several oxysterols and localizes on the surface of intracellular LDs. Silencing of ORP2 affects the rate of TG hydrolysis and the degree of cholesterol esterification, thus suggesting that ORP2 acts as a sterol receptor involved in the integrated control of cholesterol and TG metabolism.
EXPERIMENTAL PROCEDURES
cDNA constructs, site-directed mutagenesis, short interfering RNAs, and antibodies cDNAs for transient transfections were subcloned into the pcDNA4HisMaxC expression vector (Invitrogen, Carlsbad, CA), which encodes hexahistidine and Xpress™ epitope tags fused at the N terminus of the insert proteins. ORP2 cDNA engineered by PCR to remove the stop codon was also inserted in the BamHI site of pHcRed-N1 (BD Biosciences Clontech, San Jose, CA). For protein production in Escherichia coli, cDNAs were subcloned in the BamHI site of pGEX-1lT (GE Healthcare, Little Chalfont, Buckinghamshire, UK). The full-length ORP open reading frames used in this study were ORP1L (AF323726), ORP2 (BC000296), and ORP3 (NM_015550). The glutathione S-transferase (GST)-MLN64 START domain construct was a kind gift from Prof. Elina Ikonen (Institute of Biomedicine, University of Helsinki, Finland).
The sequences of ORP2 short interfering RNA (siRNA) duplexes (Sigma Genosys, St. Louis, MO) were as follows: ORP2 siRNA 1, GGGAAGAUUUAGGAUUCAGtt (sense) and CUGAAUCCUAAAUCUUCCCtg (antisense); ORP2 siRNA 2, CGUAUGAAUUAAUCAGGGAtt (sense) and UCCCUGAUUAAUUCAUACGtt (antisense); ORP2 siRNA 3, GGACACAUUCAAGACAAAAtt (sense) and UUUUGUCUUGAAUGUGUCCtt (antisense); and ORP2 siRNA 4, GGACCGGCAAACCAUUUAAtt (sense) and UUAAAUGGUUUGCCGGUCCtc (antisense). The sequences of control siRNA duplexes were UAGCGACUAAACA-CAUCAATT (sense) and UUGAUGUGUUUAGUCGCUATT (antisense). The rabbit ORP2 antibody was described in (26) . A monoclonal mouse antibody (mab) against the Xpress™ epitope tag was purchased from Invitrogen, the mab against GM-130 from BD Biosciences-Transduction Laboratories (San Jose, CA), the mab against transferrin receptor from Zymed (San Francisco, CA), the mab (clone H4A3) against Lamp1 from Developmental Studies Hybridoma Bank (Iowa City, IA), and the mab against GAPDH from Novus Biologicals (Littleton, CO). Alexa-labeled fluorescent goat secondary antibody conjugates were from Invitrogen.
Cell culture
The human epithelial carcinoma cell line A431 was grown in a 5% CO 2 atmosphere in DMEM with 4.5 g/l glucose and sodium pyruvate (Sigma-Aldrich, St. Louis, MO) supplemented with 10% FBS (Invitrogen-Gibco BRL, Carlsbad, CA), 100 IU/ml penicillin,and 100 mg/ml streptomycin at 37°C for a maximum of 30 passages. The cells were transfected with Lipofectamine 2000 (Invitrogen) according to the manufacturerʼs instructions. siRNA-mediated gene silencing was carried out with HiPerFect™ (Qiagen) according to the manufacturerʼs instructions using the fast-forward transfection protocol. LDs were induced in A431 cells by overnight treatment with 350 mM oleic acid-BSA complexes prepared according to (28) . Stably transfected ORP2 HeLa TRex cells were cultured and induced with doxycyclin as previously described (21) .
Fluorescence microscopy
A431 cells were fixed with 3% (w/v) paraformaldehyde in PBS for 30 min. Permeabilization of the cells and the blocking of nonspecific binding of antibodies were done simultaneously in PBS containing 0.5% BSA and 0.1% saponin (blocking buffer) for 30 min. Primary antibodies and secondary antibody conjugates were diluted in blocking buffer and incubated for 1 h at room temperature. When LDs were stained, 50 mM Bodipy 493/503 (Invitrogen-Molecular Probes, Carlsbad, CA) was added in the secondary antibody dilution. Washes after the antibody incubations were done three times with blocking buffer. Finally, the cover slips were washed three times with PBS and once with water, after which they were mounted in Mowiol 4-88 (Sigma-Aldrich) containing 2.5% 1,4-diazabicyclo[2.2.2]octane (Sigma-Aldrich). When antibody incubations were not required, cells were stained with 50 mM Bodipy 493/503 and with 4′,6-diamidino-2-phenylindole for 30 min before fixation. Images were acquired with Zeiss Meta or Leica TCS SP1 confocal microscopes.
Immunoelectron microscopy
For immunoelectron microscopy, A431 cells were transfected with ORP2-pcDNA4HisMaxC and loaded with 350 mM oleic acid-BSA complexes overnight. The cells were then fixed with 4% paraformaldehyde, scraped, and pelleted in gelatin. Polyvinylpyrrolidone/sucrose-infiltrated specimens were sectioned at 2110°C and picked up in methyl cellulose-sucrose. The sections were treated with 1% fish skin gelatin (Sigma-Aldrich) and 1% BSA and incubated with the ORP2 antibody (1:70) for 1 h.
Secondary antibody (Protein A-10 nm gold; University of Utrecht, The Netherlands) was applied for 1 h, and sections were embedded in uranyl acetate-methyl cellulose and examined with a Jeol 1200 EX II electron microscope.
Protein purification
GST fusion proteins of ORP2 and MLN64 (Metastatic lymph node 64) START (Steroidogenic acute regulatory protein-related lipid transfer) domain were produced in E. coli BL21(DE3) and purified on glutathione sepharose 4B (GE Healthcare) according to the manufacturerʼs instructions. Protein concentrations of the specimens were determined by the DC assay (Bio-Rad, Hercules, CA). Before oxysterol binding experiments, the protein preparations were resolved on Laemmli gels, which were stained with Coomassie blue, scanned, and analyzed using Scion Image software (http://www.scioncorp.com/). According to this, adjustment of the protein amounts added was performed to ensure that the desired concentrations of the full-length fusion proteins were reached. 
Charcoal-dextran oxysterol binding assay

Cholesterol binding assay
To be able to study the interaction of ORP2 and cholesterol in solution, cholesterol was complexed with methyl-b-cyclodextrin (mbCD; Sigma-Aldrich) according to (30) . Briefly, 1 mg of mbCD was dissolved in 1 ml of binding buffer (10 mM HEPES, pH 7.4, 50 mM KCl, and 0.02% NP-40) and added on the top of the film of cholesterol and [ 3 H]cholesterol (44 Ci/mmol; GE-HealthcareAmersham) in a glass tube. The mixture was then probe sonicated 3 3 5 min and microcentrifuged at full speed for 15 min. For the cholesterol binding assay, 50 mg of GST (negative control), GST-ORP2, or GST-MLN64 START (positive control) were bound to glutathione sepharose beads, which were then incubated with cholesterol-mbCD (330 ng cholesterol per assay) for 30 min at room temperature. Competition of the cholesterol binding was tested using a 40-fold molar excess of 22(R)-hydroxycholesterol [22(R)OHC]. After the binding, the beads were washed and the radioactivity of the supernatant, the washes, and the pellet was measured by liquid scintillation counting.
Analysis of TG synthesis and breakdown
A431 cells on six-well plates were treated with siRNAs as described above. In the case of TG synthesis assay, 350 mM oleic acid-BSA complexes containing [ 3 H]oleic acid (5 mCi per dish; 7 Ci/mmol; GE Healthcare-Amersham) were added to the cells 40 h after the transfection. The cells were harvested at different time points in 2% NaCl. Lipids were extracted using the Bligh-Dyer protocol, and the extracts were separated by TLC using hexane/ diethyl ether/acetic acid/water (65:15:1:0.25). The TLC plates were stained with iodine, the TG spots identified by comigration with a triolein standard were scraped off, and the radioactivity was measured with a liquid scintillation counter. Protein concentrations of the cell specimens were measured with the DC Protein Assay (Bio-Rad), and the results were corrected with the protein amounts. In the case of TG breakdown assay, similar [ 3 H]oleic acid-oleic acid-BSA complexes were added to cells after 24 h of transfection. After 18 h, the cells were washed three times with PBS, and the loading/labeling medium was replaced with chase medium (DMEM, 5% delipidated serum). The cells were harvested at several time points and treated further as in the TG synthesis assay.
Assay for [ 14 C]label between free cholesterol and CEs, the labeled cells were harvested in 2% NaCl and the lipids extracted using the Bligh-Dyer protocol. Aliquots of the cells were used for protein determination (see above). The neutral lipids were separated by TLC using petrolether/diethyl ether/acetic acid (60:40:1). The TLC plates were stained with iodine, the cholesterol and CE spots identified based on comigration with unlabeled standards were scraped off, and the radioactivity was measured with a liquid scintillation counter.
RESULTS
ORP2 binds several oxysterols with different affinities
We recently reported that ORP2 binds 25OHC with micromolar affinity (31) . We now wanted to study the oxysterol binding properties of ORP2 more extensively. For this, we employed a charcoal-dextran pull-down assay of [
3 H]oxysterols with GST-tagged ORP2 produced in E. coli as previously. To determine the specific binding, we performed the assays in the absence or presence of 40-fold excess of unlabeled oxysterol, and the nonspecific binding was subtracted from the total binding (Fig. 1A) . In these experiments 22(R)OHC was bound by ORP2 with the highest affinity (K d 5 1.4 3 10 28 M), followed by 7-ketocholesterol (K d 5 1.6 3 10 27 M) and 25OHC, which displayed weak but reproducible binding to the protein. However, no specific binding of 27-hydroxycholesterol was detected. We also tested the oxysterol binding properties of a mutant ORP2 (ORP2 I249W) previously shown to be defective in 25OHC binding (31) . This mutant also failed to bind 22(R)OHC (Fig. 1A) . From these assays, we conclude that ORP2 binds several oxysterols with different affinities, the highest affinity ligand so far being 22(R)OHC.
ORP2 binds cholesterol
In a previous study, we presented data suggesting that overexpressed ORP2 enhances the intracellular transport of cholesterol (21) . Therefore, we wanted to study whether ORP2 might, in addition to oxysterols, bind cholesterol. Since cholesterol is markedly more hydrophobic than oxysterols, we designed a cholesterol binding assay in ORP2 is a sterol receptor on lipid droplets 1307 by guest, on November 7, 2017 www.jlr.org Downloaded from
which [
3 H]cholesterol is solubilized using methyl-bcyclodextrin and subjected to pull down with GST-tagged recombinant proteins. The START domain of the cholesterol binding protein MLN64 was used as a positive (32) and GST as a negative control. In this assay, GST-ORP2 showed significant cholesterol binding over the background signal of GST. However, the binding was modest compared with that of the GST-MLN64 START domain (Fig. 1B) . The specificity of the binding was tested by adding a 40-fold excess of unlabeled 22(R)OHC in the assay. The cholesterol binding was efficiently competed by the oxysterol, suggesting that the binding is specific and occurs in the same pocket as that of the oxysterols, as shown for the homologous yeast protein Osh4p (33) .
ORP2 localizes to the surface of intracellular LDs
The subcellular localization of ORP2 has so far been unclear. The data of Laitinen et al. (26) suggested partial Golgi localization of human ORP2 in CHO cells, but when overexpressed in several human cell lines under standard culture conditions, the human ORP2 was diffusely distributed throughout the cytoplasm with no sign of Golgi association ( Fig. 2A-C; data not shown). In this study, Xpress epitope-tagged ORP2 was expressed in the human epithelial carcinoma cell line A431 with abundant endogenous ORP2 expression. In the normal growth medium with 10% FBS ORP2 displayed a relatively even staining of the cytoplasmic compartment with additional small dot-or ring-like ORP2-positive structures. These structures were also found to be stained with Bodipy 493/503, a neutral lipid stain, suggesting that they may represent cytoplasmic LDs ( Fig. 2A-C) . When the cells were treated overnight with 350 mM oleic acid-BSA to enhance lipogenesis and LD formation, prominent ORP2 localization on Bodipy 493/503-positive spherical structures was evident ( Fig. 2D-F) . The spherical structures were not stained with antibodies recognizing the Golgi (GM130; Fig. 2G-I ), lysosomes (Lamp1; Fig. 2J-L) , or early/recycling endosomes (transferrin receptor; Fig. 2M-O) . We thus concluded that ORP2 localizes on the surface of neutral LDs. The LD association was not unique for A431 cells: Overexpressed ORP2 displayed LD association also in other cell lines, such as HeLa, HepG2, and Cos7 (data not shown). ORP2 was also seen on the LD of stably transfected HeLa TRex cells induced to overexpress untagged ORP2 (21) (Fig. 3A-C) , demonstrating that the localization is not specific for the Xpress epitopetagged protein. Furthermore, ORP2 with the fluorescent HcRed protein fused at its C terminus displayed a similar LD localization, showing that the LD distribution is not a result from an artifactual association that could arise during the immunofluorescence staining protocol (Fig. 3D-F) . This observation also demonstrates that modification of the C terminus of ORP2 does not interfere with the LD localization.
Importantly, a faint staining of endogenous ORP2 with the rabbit antibody could be seen in the area of LD accumulation in nontransfected, oleic acid-loaded A431 cells, providing evidence that the endogenous ORP2 also associates with the LD (Fig. 3G-I) . The endogenous staining appeared punctuate, being thus somewhat different from the ring-like LD staining observed for the overexpressed ORP2. This staining vanished when the ORP2 antibody was preincubated with purified GST-ORP2 (Fig. 3J-L) , confirming the specificity of the immunoreactivity.
To test the specificity of ORP2 LD association, ORP1L and ORP3 were transfected in A431 cells loaded with oleic acid. As previously reported for other cell lines (14, 15) , ORP1L localized to late endo/lysosomal structures (see supplementary Fig. IA-C) and ORP3 to the ER and the cytosol (see supplementary Fig. 1D-F) . No colocalization of these proteins with Bodipy 493/503 was detected, suggesting that the LD association is specific for ORP2.
Immunoelectron microscopic localization of ORP2
To investigate the ORP2 localization at the ultrastructural level, we carried out cryosection immunoelectron microscopy of transfected A431 cells using the polyclonal rabbit antibody. Immunogold was detected lining LDs, while specific staining of other membrane structures was not detectable (Fig. 4) . Even though the FFAT motif of ORP2 could specify ER targeting (22) , no significant labeling of ER elements was observed. Furthermore, immunolabeling was prominent on LD surfaces at which no closely associated ER membrane was evident. This observation is consistent with the fact that no significant ER association of ORP2 was detected in immunofluorescence experiments (data not shown).
ORP2 overexpression causes dispersal of LDs
The LD in A431 cells are typically clustered at a juxtanuclear location. Fluorescence microscopy observation of oleic acid-loaded cells revealed that the distribution of the LD in cells overexpressing ORP2 was different from the neighboring untransfected cells. The droplets were no longer clustered but were dispersed throughout the cytoplasm (Fig. 5) . Even though the present observation was made under overexpression conditions, it suggests that ORP2 is capable of modulating the LD organization, which could impact the metabolism of neutral lipids in these organelles.
22(R)hydroxycholesterol inhibits the LD association of ORP2
The addition of oxysterols to cells has been shown to affect the localization of OSBP (17) and an ORP3:OSBP chimera (15) . We wanted to test if the same applies to ORP2. A431 cells overexpressing ORP2 were treated overnight with 350 mM oleic acid-BSA to induce LD formation in the presence of 5 mM 22(R)OHC. The association of ORP2 with LDs was clearly inhibited in the oxysterol-treated cells. On the vehicle (ethanol) treated control cover slips, ORP2 was associated with LDs in 63% of the transfected cells, while only 6% of the cells on 22(R)OHC-treated cover slips displayed LD association, the ORP2 showing a diffuse, often dotty cytoplasmic distribution ( Fig. 6A-C ; quantification in 6M). The same effect was detected in stably transfected HeLa cells induced to express ORP2: The 22(R) OHC treatment abolished the LD association and led to an altered distribution of ORP2 with a prominent plasma membrane aspect (Fig. 6D-F) . To investigate whether this effect is dependent on the oxysterol binding by ORP2, we expressed the oxysterol binding defective mutant I249W in A431 cells subjected to the same treatments as above. In the absence of oxysterol, the mutant associated with the LD similar to the wild type protein (Fig. 6G-I, M) . However, in contrast to wild-type ORP2, addition of 22(R)OHC did not affect the LD association of ORP2 I249W (54% of the cells; Fig. 6J-L, M) .
When testing the concentration dependency of the 22(R)OHC effect on ORP2 LD localization, we found that 0.05 mM 22(R)OHC was not able to inhibit the LD association, and 0.5 mM oxysterol had a mild effect detectable in some cells (Fig. 6N, O) . It is hard to estimate the effective intracellular oxysterol concentration reached; the 0.05 mM and possibly also the 0.5 mM concentration may be insufficient to reach full ligand occupancy in live cells. As expected, the other oxysterols displaying lower or no detectable affinity for ORP2, 7-ketocholesterol, 25OHC, and 27OHC were unable to inhibit the ORP2 LD association at 5 mM concentration (data not shown). The data suggest that ligand binding to ORP2 is capable of inducing a conformational change that inhibits the association of the protein with LD surface.
ORP2 silencing slows down the TG breakdown
To silence ORP2 expression in A431 cells, four different siRNAs were designed. Of these, ORP2 siRNAs 1, 2, and 4 showed the highest silencing efficiency compared with a control siRNA (Fig. 7A) and were used for further studies. The effect of ORP2 silencing on LD morphology was assessed. A431 cells were treated with siRNAs for 72 h in 10% fetal calf serum (FCS) and oleic acid-containing medium, after which the LD were stained with Bodipy 493/503. ORP2 silencing appeared to result in clearly increased intensity of perinuclear LD staining as compared with control siRNA-treated cells (Fig. 7B, left panels) . When the cells were first treated for 48 h with siRNAs in 10% FCS and oleic acid containing medium and then chased for 24 h in medium containing 5% delipidated FCS to induce TG breakdown, the effect of ORP2 silencing became clear. Cells treated with control siRNA lost nearly all the LDs as judged by Bodipy 493/503 staining, but the ORP2 siRNA-treated cells still had clearly visible LDs (Fig. 7B, right panels) , suggesting that the silencing of ORP2 stabilizes the LD and slows down the mobilization of neutral lipids.
To investigate the phenomenon using a biochemical approach, A431 cells were treated with control or ORP2 siRNAs and labeled for 16 h with a mixture of unlabeled and [ 
ORP2 silencing increases CEs in oleic acid-loaded cells
In addition to TGs, LDs store cholesterol in the form of CEs. Since there are suggested connections between the metabolism of TG and CE in LDs (34, 35) , we wanted to study the effect of ORP2 silencing on cholesterol esterification in A431 cells in normal growth medium or under oleic In the normal growth conditions (DMEM, 10% FBS), ORP2 silencing had no effect on the quantity of [ 14 C]CE (Fig. 8) . When TG synthesis and LD formation were enhanced by overnight treatment with oleic acid-BSA, a difference between cells treated with 14 C]CE was also increased in control siRNA treated cells upon oleic acid-BSA treatment, probably due the fact that oleic acid is a good substrate for ACAT (36, 37) .
DISCUSSION
The starting point of this study is the novel finding that ORP2 localizes on intracellular LDs. The LD localization was prominent when the cells were loaded with oleic acid-BSA complexes, but ORP2 could be detected on LDs also in unloaded cells. The localization was detected in a number of human cell lines, and its specificity was controlled for in several ways. Although ORP2 localizes to the LD in every cell model we have studied, the protein has not been identified as a LD component in the studies identifying the mammalian LD proteome (38) (39) (40) (41) . Consistently, we were unable to detect endogenous ORP2 in LD fractions of A431 cells using the sucrose gradient isolation procedure described in (42) (data not shown). We find it likely that ORP2 readily dissociates from the LD during the gradient centrifugation procedures used for LD isolation.
We identified 22(R)OHC as the highest affinity ligand of ORP2 among the oxysterols tested, the K d 1. Silencing of ORP2 stabilizes cellular TGs. A: Lysates (20 mg of total protein) of A431 cells treated with a control and four ORP2 specific siRNAs (1-4, indicated on the top) were analyzed by Western blotting. ORP2 was detected with polyclonal rabbit antibodies, and GADPH antibody was used to control for equal protein loading. B: A431 cells were either treated with siRNAs for 72 h in 10% FCS and oleic acid-containing medium (panels labeled "FCS") or treated for 48 h with siRNAs in 10% FCS and oleic acid-containing medium and then chased for 24 h in medium containing 5% delipidated FCS (panels labeled "chase"). The cells were fixed and stained with Bodipy 493/503 and 4′,6-diamidino-2-phenylindole to visualize LDs and nuclei, respectively. Bar 5 10 mm. C: A431 cells were treated with control siRNA or ORP2 siRNA 1 and subjected to a 16-h treatment with 350 mM [ 3 H]oleic acid-BSA, after which they were chased in medium containing 5% delipidated serum and harvested at different time points. The amount of [ ORP2 is a sterol receptor on lipid droplets 1313 by guest, on November 7, 2017 www.jlr.org Downloaded from resides in the cytosol or cytoplasmic vesicles and in the ER in the absence of oxysterol ligand and translocates to Golgi membranes when 25OHC is added (17) . Thereby ligand binding activates OSBP function in ceramide transport from the ER to the Golgi complex, resulting in enhanced sphingomyelin synthesis (45) . One interpretation of our data is that ORP2 differs from OSBP in its functional regulation by ligand. The effects of ORP2 silencing on neutral lipid metabolism would be consistent with a function at the LD surface, and ligand binding could in this case remove the protein from its site of function. However, we do not know whether ORP2 on the LD surface is unliganded or occupied by an unknown endogenous cellular ligand that might be displaced by the added 22(R)OHC. The fact that the mutant ORP2 I249W localizes constitutively on the LD indicates that unliganded ORP2 may be capable of LD association. Liganding of OSBP by cholesterol or 25OHC has distinct effects on OSBP function in modulating the phosphorylation and activity of extracellular signal-regulated kinases: Cholesterol-OSBP facilitates dephosphorylation of the extracellular signal-regulated kinase, while the oxysterol-bound OSBP fails to do this (46) . The present data leave open the interesting question whether interaction of ORP2 with cholesterol or oxysterols might similarly result in different functional outcomes. Detailed characterization of the functional role of ORP2 ligand occupancy remains a topic for future studies.
A common property of a number of LD proteins is the ability to shift dynamically between LD and the ER (47, 48) or the plasma membrane (49, 50) induced by changes in cellular fatty acid or cholesterol supply. Our data suggest that ORP2 behaves in a similar fashion. Known LD proteins do not seem to have any common LD targeting motif. Small Rab GTPases associate with LD via a C-terminal hydrophobic isoprenoid moiety. Caveolin-1, NADH sterol dehydrogenase-like protein, and diacylglycerol acyl transferase 2 are inserted into the LD surface and core lipid via a long hydrophobic segment most likely forming a hairpinlike structure [reviewed in (25) ]. The exact determinants for LD targeting of the perilipin-adipophilin-TIP47 family proteins, major LD surface components, are even today somewhat controversial. However, these proteins appear to use amphipatic a-helices for binding to the LD surface phospholipid monolayer (25, 51) . Based on the present data, the molecular model of ORP2 structure (31) , and the highresolution structure of Osh4p (33), we envision that the ORP2 lid region and N terminus regulate the LD association in a ligand-dependent manner. Whether the ability of ORP2 to bind acidic phospholipids (21) plays a role in the LD targeting is an interesting issue to be addressed in future work.
What is the function of ORP2? The present finding that ORP2 binds cholesterol suggests that the previously observed enhanced cholesterol transport in cell overexpressing ORP2 (21, 26) may be due to an excess of exogenous cytosolic ORP2 capable of transferring cholesterol between membranes. We now believe that the major function of ORP2 occurs on LD and involves the metabolism of TGs and CEs. The silencing of ORP2 resulted in a decreased rate of TG hydrolysis under lipid depletion conditions, suggesting that the endogenous ORP2 facilitates the breakdown of TG in this situation. Furthermore, in oleic acid-loaded cells, ORP2 knockdown resulted in increased cellular [ 14 C]CE in radiolabeling experiments. These findings are in accordance with previous results demonstrating a decrease in both cellular TG and CE in CHO cells overexpressing ORP2 (27) . The mechanism by which ORP2 could contribute to lipolysis is at present not known; it could plausibly act to facilitate the hydrolytic activity of the major lipases acting sequentially on the LD TGs, adipocyte triglyceride lipase, hormone-sensitive lipase, and monoacylglycerol lipase (52) . We made attempts to elucidate by coimmunoprecipitation whether ORP2 might interact physically with adipocyte triglyceride lipase present abundantly in A431 cells, but the results were not conclusive (data not shown).
This study forms a starting point for investigation of the detailed mechanisms by which ORP2 impacts on neutral lipids. Our results identify ORP2 as a sterol receptor present on LD and provide evidence for its role in the regulation of neutral lipid metabolism, putatively as a factor that integrates the cellular metabolism of TGs with that of cholesterol.
